Sapio Sciences | GenomeWeb

Sapio Sciences

Under the terms of the agreement, DNAnexus will make Sapio's LIMS software available on its genomics infrastructure.

IDBS has released ActivityBase XE 7.7, which provides enhanced screening and analysis functionality.

Sapio Sciences has launched Exemplar NGS LIMS to track next-generation sequencing workflows from request through processing and analysis.

Mount Sinai Medical Center has selected Sapio Sciences' Exemplar laboratory information management system solution to track and manage next-generation sequencing workflows run in its genomics core facility.

Sapio Sciences said this week that the New York Genome Center has selected its Exemplar laboratory information management system to manage operations in its next-generation sequencing labs.

Sapio Sciences said this week that its Exemplar LIMS now works on tablet computers.

This week, Genedata released Genedata Selector for Beer, Wine, and Spirits, a platform which is to analyze the genomes of brewing yeast and other microbes vital to the fermentation processes.

Pacific Biosciences said this week that customers of its Single Molecule Real Time sequencer now have access to a number of informatics analysis options and laboratory information management systems through its partner program. These include:

This week, Sapio Sciences released Exemplar Dx LIMS, a version of its laboratory information management system designed specifically for the molecular diagnostic market.

Sapio Sciences said this week that the Epigenetics Center of the Institute for Basic Biomedical Sciences at Johns Hopkins University has licensed its Exemplar Laboratory Information Management System and Electronic Lab Notebook software.

Pages

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.